$10.02
0.000.00%
Pre-Market: 5:05 PM EDT
Comments
Loading...
Edge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
AlloVir Stock Price, Quotes and Forecasts | NASDAQ:ALVR | Benzinga
Explore AlloVir stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ALVR.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy AlloVir (ALVR) stock?
You can purchase shares of AlloVir (NASDAQ:ALVR) through any online brokerage.
Who are AlloVir (ALVR) competitors?
Other companies in AlloVir’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Serina Therapeutics (AMEX:SER), CytomX Therapeutics (NASDAQ:CTMX), Gain Therapeutics (NASDAQ:GANX) and Connect Biopharma Hldgs (NASDAQ:CNTB).
What is the forecast, or price target, for AlloVir (ALVR) stock?
AlloVir has a consensus price target of $9.86.
What is the current price for AlloVir (ALVR)?
The stock price for AlloVir (NASDAQ: ALVR) is $10.015 last updated March 3, 2025 at 5:05 PM EST.
Does AlloVir (ALVR) pay a dividend?
There are no upcoming dividends for AlloVir.
When is AlloVir (NASDAQ:ALVR) reporting earnings?
AlloVir’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is AlloVir (ALVR) going to split?
There is no upcoming split for AlloVir.
What sector and industry does AlloVir (ALVR) operate in?
AlloVir is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.